Histamine structure
|
Common Name | Histamine | ||
|---|---|---|---|---|
| CAS Number | 51-45-6 | Molecular Weight | 111.145 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 331.0±17.0 °C at 760 mmHg | |
| Molecular Formula | C5H9N3 | Melting Point | 83-84ºC | |
| MSDS | Chinese USA | Flash Point | 180.3±8.1 °C | |
| Symbol |
GHS06, GHS08 |
Signal Word | Danger | |
Use of HistamineHistamine is an organic nitrogenous compound involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter. |
| Name | histamine |
|---|---|
| Synonym | More Synonyms |
| Description | Histamine is an organic nitrogenous compound involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 331.0±17.0 °C at 760 mmHg |
| Melting Point | 83-84ºC |
| Molecular Formula | C5H9N3 |
| Molecular Weight | 111.145 |
| Flash Point | 180.3±8.1 °C |
| Exact Mass | 111.079643 |
| PSA | 54.70000 |
| LogP | -0.92 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.567 |
| Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315-H317-H319-H334-H335 |
| Precautionary Statements | P261-P280-P301 + P310-P305 + P351 + P338-P342 + P311 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R36/37/38;R42/43 |
| Safety Phrases | S22-S26-S36/37 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | MS1050000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933290090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Clonal differences in IgE antibodies affect cutaneous anaphylaxis-associated thermal sensitivity in mice.
Immunol. Lett. 162(1 Pt A) , 149-58, (2014) Cellular and molecular mediators of immune responses are increasingly implicated in acute and chronic pain pathophysiologies. Here we demonstrate that passive cutaneous IgE/Ag anaphylaxis provokes inc... |
|
|
Histamine inhibits differentiation of skin fibroblasts into myofibroblasts.
Biochem. Biophys. Res. Commun. 463 , 434-9, (2015) Histamine and TGF-β, major mediators secreted by mast cells, are involved in skin inflammation and play critical roles in the pathogenesis of systemic sclerosis. However, the roles of signaling mechan... |
|
|
Inhibition of TRPM7 channels reduces degranulation and release of cytokines in rat bone marrow-derived mast cells.
Int. J. Mol. Sci. 15(7) , 11817-31, (2014) mast cells play an important role in airway inflammation in asthma. The transient receptor potential melastatin-like 7 (TRPM7) channel is expressed in primary human lung mast cells and plays a critica... |
| 2-(1H-imidazol-4-yl)ethanamine |
| istamina |
| 4-(2-aminoethyl)imidazole |
| 2-(4-imidazolyl)-1-ethylamine |
| Theramine |
| L-HISTAMINE |
| EINECS 200-100-6 |
| 1H-imidazole-4-ethanamine |
| HIS ELISA |
| Eramine |
| Eramin |
| 2-(4-imidazolyl)-ethyl amine |
| HISTAMIN |
| Histamine |
| MFCD00005210 |
| 2-(4-Imidazolyl)ethylamine |
| Ergotidine |
| Ergamine |